跳至主要内容
临床试验/NCT00705913
NCT00705913终止不适用

A Randomized Study to Compare Sizing, Implant Techniques and Hemodynamic Performance Between the Mitroflow and the Carpentier-Edwards Magna Pericardial Tissue Valves in the Aortic Position

Sorin Group USA, Inc.24 个研究点 分布在 2 个国家目标入组 368 人开始时间: 2008年6月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
368
试验地点
24
主要终点
Determine which of the two valve types, the Mitroflow or Magna valve, will demonstrate lower pressure gradients relative to aortic annulus

研究概览

简要总结

The purpose of this study is to compare sizing,implant techniques, and hemodynamics between the Mitroflow Pericardial Aortic Valve and the Edwards Magna Heart Valve.

详细描述

Comparisons of valve types are often made according to labeled valve sizes. There is growing evidence that in the majority of cases the actual sizer and valve dimensions vary from the labeled diameters, which may not be related to any hemodynamically meaningful dimension. The disagreement between the true valve dimensions and the labeled valve size may render comparisons based on labeled size meaningless

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who are indicated for implant with a bioprosthetic valve in the aortic position according to the current practice for valve selection at the center.

排除标准

  • Less than 18 years of age
  • Emergency Surgery
  • Pre-existing valve prothesis in the aortic position
  • Aortic root replacements or enlargements
  • Active endocarditis

结局指标

主要结局

Determine which of the two valve types, the Mitroflow or Magna valve, will demonstrate lower pressure gradients relative to aortic annulus

时间窗: 6 months

次要结局

  • Determine which of the two valve types, the Mitroflow or Magna valve, will demonstrate higher ratio of EOA to the aortic annulus area.(6 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (24)

Loading locations...

相似试验